Fundamental and quant desks get the whole file, a built model, a defensible memo and point-in-time data that does not peek, so the hours go into judgement rather than assembly.
A full three-statement model and valuation on every name, in your own workbook. You change the assumptions; it is not a locked black box.
MD&A, press releases and earnings transcripts sit right beside the numbers, so the story and the figures are read in one place.
Statements, the built model and a cited first-draft memo are already there, so a new name goes from blank to a view the same day.
When a company reports, the model and profile roll to the new filing on their own, so maintenance stops eating the quarter.
As-first-reported and restated figures are held apart and date-stamped, so a test sees only what the market knew at the time.
Every figure links to the filing behind it, so a challenge from the PM or compliance is answered on the spot.
A live name, the way it lands when you open it. Move through with the arrows or dots.
Per-share fair value by method, low to high. ABI Nexa research, from company filings.
| Section | What the draft already says |
|---|---|
| The stated view | Fair value 245.22 vs 168.53 spot, a gap the tape is not pricing |
| What is priced in | 68.5x forward earnings and 4.0x sales, mid-teens growth held for a decade |
| Bull | Space and defense demand lifts utilisation through the cycle |
| Bear | A single large customer and a working-capital drag on cash |
| Vintage | Value | Known as of |
|---|---|---|
| As first reported | 5.14 | Feb 2022 |
| Latest restated | 5.02 | Feb 2024 |
The statements, the built model and a cited memo are already there when you open the name.
0 wrong numbers on the audited samplePoint-in-time vintages, so a test sees only what was known on the date.
as first reportedEvery number carries the filing it came from, so a challenge is one click from its answer.
cited to the filingChange the assumptions in a model you did not have to build, on facts you did not have to gather.
The vintages are held separately, so a backtest does not peek and a decision is judged on what was known.
Tell us the names and markets you follow and we will show you the desk on them.